Literature DB >> 17437547

Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.

Maria Martire1, Monia D'Amico, Elisabetta Panza, Francesco Miceli, Davide Viggiano, Francesco Lavergata, Fabio Arturo Iannotti, Vincenzo Barrese, Paolo Preziosi, Lucio Annunziato, Maurizio Taglialatela.   

Abstract

KCNQ2 and KCNQ3 subunits encode for the muscarinic-regulated current (I(KM)), a sub-threshold voltage-dependent K+ current regulating neuronal excitability. In this study, we have investigated the involvement of I(KM) in dopamine (DA) release from rat striatal synaptosomes evoked by elevated extracellular K+ concentrations ([K+]e) and by muscarinic receptor activation. [3H]dopamine ([3H]DA) release triggered by 9 mmol/L [K+]e was inhibited by the I(KM) activator retigabine (0.01-30 micromol/L; Emax = 54.80 +/- 3.85%; IC50 = 0.50 +/- 0.36 micromol/L). The I(KM) blockers tetraethylammonium (0.1-3 mmol/L) and XE-991 (0.1-30 micromol/L) enhanced K+-evoked [3H]DA release and prevented retigabine-induced inhibition of depolarization-evoked [3H]DA release. Retigabine-induced inhibition of K+-evoked [3H]DA release was also abolished by synaptosomal entrapment of blocking anti-KCNQ2 polyclonal antibodies, an effect prevented by antibody pre-absorption with the KCNQ2 immunizing peptide. Furthermore, the cholinergic agonist oxotremorine (OXO) (1-300 micromol/L) potentiated 9 mmol/L [K+]e-evoked [3H]DA release (Emax = 155 +/- 9.50%; EC50 = 25 +/- 1.80 micromol/L). OXO (100 micromol/L)-induced [3H]DA release enhancement was competitively inhibited by pirenzepine (1-10 nmol/L) and abolished by the M3-preferring antagonist 4-diphenylacetoxy N-methylpiperidine methiodide (1 micromol/L), but was unaffected by the M1-selective antagonist MT-7 (10-100 nmol/L) or by Pertussis toxin (1.5-3 microg/mL), which uncouples M2- and M4-mediated responses. Finally, OXO-induced potentiation of depolarization-induced [3H]DA release was not additive to that produced by XE-991 (10 micromol/L), was unaffected by retigabine (10 micromol/L), and was abolished by synaptosomal entrapment of anti-KCNQ2 antibodies. Collectively, these findings indicate that, in rat striatal nerve endings, I(KM) channels containing KCNQ2 subunits regulate depolarization-induced DA release and that I(KM) suppression is involved in the reinforcement of depolarization-induced DA release triggered by the activation of pre-synaptic muscarinic heteroreceptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437547     DOI: 10.1111/j.1471-4159.2007.04562.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.

Authors:  Jacob Bendor; José E Lizardi-Ortiz; Robert I Westphalen; Markus Brandstetter; Hugh C Hemmings; David Sulzer; Marc Flajolet; Paul Greengard
Journal:  EMBO J       Date:  2010-07-27       Impact factor: 11.598

Review 2.  Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.

Authors:  Henrik H Hansen; Olivier Waroux; Vincent Seutin; Thomas J Jentsch; Susana Aznar; Jens D Mikkelsen
Journal:  J Physiol       Date:  2008-01-03       Impact factor: 5.182

3.  Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.

Authors:  H Kubista; K Kosenburger; P Mahlknecht; H Drobny; S Boehm
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

4.  Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity.

Authors:  Noa Regev; Nurit Degani-Katzav; Alon Korngreen; Adi Etzioni; Sivan Siloni; Alessandro Alaimo; Dodo Chikvashvili; Alvaro Villarroel; Bernard Attali; Ilana Lotan
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

5.  Role of neuronal potassium M-channels in sympathetic regulation of cardiac function.

Authors:  I Michaelevski; I Lotan
Journal:  J Physiol       Date:  2011-06-01       Impact factor: 5.182

6.  Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels.

Authors:  Limin Shi; Xiling Bian; Zhiqiang Qu; Zegang Ma; Yu Zhou; KeWei Wang; Hong Jiang; Junxia Xie
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Functional role of M-type (KCNQ) K⁺ channels in adrenergic control of cardiomyocyte contraction rate by sympathetic neurons.

Authors:  Oleg Zaika; Jie Zhang; Mark S Shapiro
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

Review 8.  Novel medications for epilepsy.

Authors:  Cinzia Fattore; Emilio Perucca
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

9.  Enhancing m currents: a way out for neuropathic pain?

Authors:  Ivan Rivera-Arconada; Carolina Roza; Jose A Lopez-Garcia
Journal:  Front Mol Neurosci       Date:  2009-08-04       Impact factor: 5.639

10.  The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes.

Authors:  Sigrid Marie Blom; Nicole Schmitt; Henrik Sindal Jensen
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.